Live search
TopFind is fetching the latest matches for your search.
We reviewed 4 live results for abrilada and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Tnf Inhibitors.
Source: Pfizer Private Limited
Description
Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases.
Best for
biologic therapy, chronic inflammation management and subcutaneous injection
Rating
Source: Pfizer Malaysia
Description
Abrilada is a biologic immunomodulator and TNF-alpha inhibitor available as a 40 mg/0.8 mL solution for injection in a pre-filled pen. It is a biosimilar indicated for various autoimmune conditions.
Best for
autoimmune conditions, biologic therapy and TNF-alpha inhibition
Rating
Source: Pfizer Inc.
Description
ABRILADA (adalimumab-afzb) is a biologic medication and tumor necrosis factor (TNF) blocker designed to treat various inflammatory conditions. As an FDA-approved interchangeable biosimilar to Humira®, it can be substituted at the pharmacy level. This citrate-free medication is indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. It is available in several forms including a single-dose prefilled pen (ABRILADA Pen), single-dose prefilled syringe, and institutional use vial in various strengths.
Best for
rheumatoid arthritis patients, humira biosimilar alternatives, adults with plaque psoriasis, citrate-free injection preference and crohn's disease management
Rating
| Compare | Abrilada | Abrilada | ABRILADA (adalimumab-afzb) |
|---|---|---|---|
| Source | Pfizer Private Limited | Pfizer Malaysia | Pfizer Inc. |
| Description | Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases. | Abrilada is a biologic immunomodulator and TNF-alpha inhibitor available as a 40 mg/0.8 mL solution for injection in a pre-filled pen. It is a biosimilar indicated for various autoimmune conditions. | ABRILADA (adalimumab-afzb) is a biologic medication and tumor necrosis factor (TNF) blocker designed to treat various inflammatory conditions. As an FDA-approved interchangeable biosimilar to Humira®, it can be substituted at the pharmacy level. This citrate-free medication is indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. It is available in several forms including a single-dose prefilled pen (ABRILADA Pen), single-dose prefilled syringe, and institutional use vial in various strengths. |
| Best for | biologic therapy, chronic inflammation management and subcutaneous injection | autoimmune conditions, biologic therapy and TNF-alpha inhibition | rheumatoid arthritis patients, humira biosimilar alternatives, adults with plaque psoriasis, citrate-free injection preference and crohn's disease management |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Abrilada from Pfizer Private Limited."
I picked this because An HSA-approved alternative from a major manufacturer, offering standard injection formats.